PharmEasy is staring at hard times
The online drugs and medical services startup made some costly acquisitions in a bid to pull off an IPO at a high valuation. That plan may be coming unstuck.
21 July, 2022•5 min
0
21 July, 2022•5 min
0
More in Business
Business
In Swiggy’s Rs 10,000 crore QIP, mutual funds emerge the largest investors
ICICI Prudential, SBI MF and Aditya Birla Sun Life MF account for 37% of the delivery giant’s fundraise.
You may also like
Internet
Peak XV Partners should win the record outcome test with Pine Labs
Finally, this question will be answered. Who has returned the most amount of capital on any venture investment in India in the last two decades?
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
Internet
Can Naveen Tahilyani fix Tata Digital’s rot?
The flop show of the super app Tata Neu isn’t the biggest problem for Tata Sons chairman N Chandrasekaran. The new CEO he has now picked has more fundamental issues to fix.